Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Cancer Treatment Reviews
|
October 2, 2018
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine
Ahmad Tarhini, Ragini R Kudchadkar
Surgical Oncology Clinics of North America
|
June 3, 2020
Neoadjuvant Therapy for Melanoma
Michael C Lowe, Ragini R Kudchadkar
Cancer Control : Journal of the Moffitt Cancer Center
|
June 24, 2014
BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies
Richard D Hall, Ragini R Kudchadkar
Cancer Control : Journal of the Moffitt Cancer Center
|
October 1, 2013
New targeted therapies in melanoma
Ragini R Kudchadkar, Rene Gonzalez, Karl Lewis
Expert Opinion on Drug Safety
|
February 5, 2015
BRAF and MEK inhibition in melanoma
Lesly A Dossett, Ragini R Kudchadkar, Jonathan S Zager
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Practice-Changing Developments in Stage III Melanoma: Surgery, Adjuvant Targeted Therapy, and Immunotherapy
Ragini R Kudchadkar, Olivier Michielin, Alexander C J van Akkooi
CA: a Cancer Journal for Clinicians
|
March 29, 2014
Recent developments in the medical and surgical treatment of melanoma
Vita Saranga-Perry, Chenwi Ambe, Jonathan S Zager, et al.
Current Problems in Cancer
|
October 5, 2014
Section IV: non-small cell lung cancer and malignant melanoma
Kevin E Fisher, Rathi N Pillai, Ragini R Kudchadkar, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 1, 2013
Recent advances in the treatment of melanoma
Jonathan S Zager, Amod A Sarnaik, Geoffrey T Gibney, et al.
CA: a Cancer Journal for Clinicians
|
February 27, 2020
Metastatic melanoma
Ragini R Kudchadkar, Michael C Lowe, Mohammad K Khan, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Cancer Treatment Reviews
|
October 2, 2018
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine
Ahmad Tarhini, Ragini R Kudchadkar
Surgical Oncology Clinics of North America
|
June 3, 2020
Neoadjuvant Therapy for Melanoma
Michael C Lowe, Ragini R Kudchadkar
Cancer Control : Journal of the Moffitt Cancer Center
|
June 24, 2014
BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies
Richard D Hall, Ragini R Kudchadkar
Cancer Control : Journal of the Moffitt Cancer Center
|
October 1, 2013
New targeted therapies in melanoma
Ragini R Kudchadkar, Rene Gonzalez, Karl Lewis
Expert Opinion on Drug Safety
|
February 5, 2015
BRAF and MEK inhibition in melanoma
Lesly A Dossett, Ragini R Kudchadkar, Jonathan S Zager
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
Practice-Changing Developments in Stage III Melanoma: Surgery, Adjuvant Targeted Therapy, and Immunotherapy
Ragini R Kudchadkar, Olivier Michielin, Alexander C J van Akkooi
CA: a Cancer Journal for Clinicians
|
March 29, 2014
Recent developments in the medical and surgical treatment of melanoma
Vita Saranga-Perry, Chenwi Ambe, Jonathan S Zager, et al.
Current Problems in Cancer
|
October 5, 2014
Section IV: non-small cell lung cancer and malignant melanoma
Kevin E Fisher, Rathi N Pillai, Ragini R Kudchadkar, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 1, 2013
Recent advances in the treatment of melanoma
Jonathan S Zager, Amod A Sarnaik, Geoffrey T Gibney, et al.
CA: a Cancer Journal for Clinicians
|
February 27, 2020
Metastatic melanoma
Ragini R Kudchadkar, Michael C Lowe, Mohammad K Khan, et al.
Page
of 6